To the Editor:
The link between depression and diabetes, late complications and glycaemic control is well established [1, 2, 3] . In routine care, a considerable proportion of patients with depression remains undetected and untreated [4, 5] . As diabetes requires self management, depression leads to a higher risk of diabetic late complications. The WHO (five) Well-Being Index (WB5) is a short screening instrument for the detection of depression in the general population. This instrument is also recommended in the WHO DiabCare Basic Information Sheet (BIS). WB5 was developed within the DepCare [6] project as a first-line low-mood screening instrument for depression. It is a short five-item questionnaire, whereby every answer is given a score between 0 and 5, yielding a raw score of between 0 and 25. A raw score below 13 indicates poor well-being and is considered to be an indicator of depression, which should be confirmed using the Major (ICD-10) Depression Inventory and through specific patient interviews [6] . WB5 has been evaluated in elderly patients, and showed adequate internal and external validity [7] .
The Forum for Quality Systems in Diabetes Care (FQSD) is a voluntary multinational quality improvement initiative, active in Germany and Austria. More than 170 healthcare centres (GPs and hospitals) participate actively in the FQSD initiative and collect more than 20,000 BIS yearly. Quarterly, regional centres send all participating centres non-anonymised qualityof-care reports, addressing issues of structure, process and outcome measures. Additionally, data collection and quality-ofcare benchmarks can be performed online at any time. This analysis was carried out in accordance with the Declaration of Helsinki and was approved by the local ethics committee. Participating patients gave informed consent.
Since or HbA 1 c. Furthermore, lower proportions of some diabetesrelated complications were found among screened patients: acute ulceration (3.6% vs 6.7%, p<0.001), myocardial infarction (11.3% vs 12.3%, p=0.008), amputation (2% vs 2.8%), neuropathy (25% vs 31.5%, p<0.001), and nephropathy (5.6% vs 7.6%). The prevalence of angina pectoris was higher among screened patients (12.6% vs 11%). Prevalence of retinopathy, stroke and claudication were not significantly different between the screened and non-screened patients.
In Type 2 diabetes patients, the prevalence of low WB5 scores was 26.8% (95% CI: 25.2-28.4%) in males and 34.5% (95% CI: 32.9-36.1%) in females. WB5 scores below 13 were associated with categorical variables presented in Figure 1 The prevalence of depressive symptoms among diabetic patients in our population is high, but nevertheless in line with other predominantly clinical diabetic populations. Quarterly feedback in a quality management system increased the percentage of patients screened for depression. The WB5 questionnaire can be completed in less than 5 minutes, and should be more widely used for depression screening among persons with diabetes.
